Developing and manufacturing drugs is more expensive and complicated than ever before. Many outsource to CDMO's, but which approach truly offers th...
Small molecules are now able to target previously ‘undruggable’ conditions, such as cancers and neurological disorders, I discuss how we got here a...
In part two of this discussion, Dennis and I discuss the key barriers for entry for companies expanding into new territories and how to overcome th...
In this final part, Dennis and I discuss new technologies to watch in the liquid biopsy market, as well as insights into innovation from behind the...
Predicine With a background in research, pharma and commercial, Dennis gives insight into the true value of liquid biopsy. Click to listen.
Alongside COVID, most sponsors saw a significant shift to a more patient-centric approach in 'decentralized clinical trials'. But what does this me...
In CM Life Science's latest webinar, we discussed how data translates into the lab world, the challenges surrounding data maturity and what lab dat...
View moreCM Conversations is a podcast brought to you by Charlton Morris. We speak to thought leaders from the world of business, as well as the markets we serve.
Looking for something specific? Select a topic below to just browse the subject you’re interested in.
Introducing YourFeed, the latest addition to searchinglifescience.com meaning that you never miss the latest content about the topics that matter to you. Set up an account, set your preferences and let the latest articles, videos and podcasts come to you. We’ll also be adding exclusive content to YourFeed subscribers soon, so watch this space.
Signup
